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Background: Inguinal hernias are common in less economically developed countries (LEDCs), and asso-
ciated with significant morbidity and mortality. Tension-free mesh repair is the standard treatment
worldwide. Lack of resources combined with the high cost of commercial synthetic mesh (CSM) have
limited its use in LEDCs. Sterilized mosquito net mesh (MNM) has emerged as a low-cost, readily avail-
able alternative to CSM. The aim of this systematic review and meta-analysis was to evaluate the safety
and efficacy of MNM for the use in hernia repair in LEDCs.
Methods: A systematic review and data meta-analysis of all published articles from inception to August
2018 was performed. Cochrane Central Register of Controlled Trials, MEDLINE and Embase databases
were searched. The primary outcome measure was the overall postoperative complication rate of hernia
repair when using MNM. Secondary outcome measures were comparisons between MNM and CSM
with regard to overall complication rate, wound infection, chronic pain and haematoma formation.
Results: A total of nine studies were considered relevant (3 RCTs, 1 non-randomized trial and 5
prospective studies), providing a total cohort of 1085 patients using MNM. The overall complication
rate for hernia repair using MNM was 9⋅3 per cent. There was no significant difference between MNM
and CSM regarding the overall postoperative complication rate (odds ratio 0⋅99, 95 per cent c.i. 0⋅65
to 1⋅53; P=0⋅98), severe or chronic pain (OR 2⋅52, 0⋅36 to 17⋅42; P= 0⋅35), infection (OR 0⋅56, 0⋅19 to
1⋅61; P=0⋅28) or haematoma (OR 1⋅05, 0⋅62 to 1⋅78; P= 0⋅86).
Conclusion: MNMhas a low overall postoperative complication rate and is unlikely to be inferior to CSM
in terms of safety and efficacy. MNM is a suitable low-cost alternative to CSM in the presence of financial
constraint.
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Introduction
Hernia repair is one of the most commonly performed
surgical operations worldwide1. Less economically devel-
oped countries (LEDCs) often have a significant number
of people with inguinal hernia, with an estimated preva-
lence of 3⋅2 (range 2⋅8–3⋅5) per cent in Ghana2. The inci-
dence of symptomatic hernia in Africa is reported to be
approximately 200 per 100000 people3, and in Tanzania
the incidence is as high as 5⋅4 per cent4. In both studies2,4
the prevalence of inguinal hernia was compared against
the current rate of hernia repair, and it was determined
that there would be a backlog of approximately 1 mil-
lion patients over a 10-year period. This significant
burden of surgical work has been recognized for more
than 30 years5. Strangulated inguinal hernia has been
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Fig. 1 PRISMA diagram for the review
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reported to have a mortality rate of as high as 40 per
cent in low-income countries6. The prevalence of symp-
tomatic hernia may be associated with delayed repair,
and thus higher morbidity and mortality. Beyond this,
poor infrastructure, shortage of medical facilities and low
numbers of surgeons per population are issues faced by
many LEDCs7.
In the mid 1980s, Lichtenstein tension-free repair was
advocated to deal with inguinal hernia in a way that avoided
reliance on sutures and associated suture tension8,9. Licht-
enstein hernia repair with a commercial synthetic mesh
(CSM) is now the most common technique used in the
developed world10. A recent Cochrane review11 concluded
that the use of mesh was associated with fewer recurrences,
a shorter duration of surgery and a shorter length of hospi-
tal stay compared with non-mesh repair. However, the cost
of CSM has remained prohibitive in LEDCs12. Sterilized
mosquito net mesh (MNM) may be a low-cost alternative
in these countries as an easily accessible substitute13.
The cost of importing CSM to low-income countries
is commonly reported to be approximately €9013,14. This
is in stark contrast to MNM, which costs consistently
less than €1 for the material itself13–15. Following this,
the mesh must be sterilized and packaged. Sterilization
is most commonly carried out using an autoclave, which
is cost-effective and used widely throughout sub-Saharan
Africa16. Even taking into consideration the cost of local
sterilization and packing, MNM remains considerably
cheaper than CSM.
CSM is commonly made from polypropylene, which is
easily sterilized. MNM is usually made from a number
of materials, including a co-polymer of polyethylene and
polypropylene14 in varying proportions, reflecting manu-
facturer and country of origin. This variation can impact on
the material properties of the mesh, related to the method
of sterilization used17.
The aims of the presented systematic review and meta-
analysis were to evaluate current evidence investigating the
safety and efficacy of MNM for groin hernia in LEDCs.
The primary outcome measure was the overall postop-
erative complication rate of hernia repair using MNM.
Secondary outcome measures were comparisons between
MNM and CSM with regard to overall complication rates,
wound infection, chronic pain and haematoma formation.
© 2019 The Authors. www.bjsopen.com BJS Open 2019; 3: 429–435
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Table 1 Risk-of-bias summary of individual RCTs and non-randomized controlled trial assessed by Cochrane risk-of-bias checklist
Random sequence
generation
(selection bias)
Allocation
concealment
(selection bias)
Blinding of
participants
and personnel
(performance bias)
Blinding of
outcome assessment
(detection bias)
Incomplete outcome
data
(attrition bias)
Selective
reporting
(reporting bias)
Other
bias
Chauhan et al.21 + + + + + + +
Freudenberg et al.13 ? + + + ? + +
Löfgren et al.20 + + + + + + +
Tongaonkar et al.14 − − − + ? + ?
+, Low risk of bias; ?, unclear risk of bias; −, high risk of bias.
Methods
This systematic review and meta-analysis was conducted
according to a predefined protocol and in accordance
with the principles recommended in the PRISMA
guidelines18 (Fig. 1).
Eligible studies were included provided they met the fol-
lowing criteria: RCT, non-randomized controlled trial or
observational study relating to clinical studies on humans
involving NMN for hernia repair, either in isolation or in
comparison with CSM. Only original studies containing
original data were included.
Animal studies, non-English-language studies, studies for
which only an abstract was available, non-clinical studies,
studies with duplicate data, and narrative reviews were all
excluded.
Data sources
Eligible studies were identified by performing searches
in the Cochrane Central Register of Controlled Trials,
PubMed/MEDLINE and Embase, as resources to identify
relevant manuscripts. Search term key words were ‘hernia’,
‘mesh’, ‘mosquito mesh’ and ‘hernia repair’. Databases
were searched from inception to August 2018. Reference
lists of relevant studies were also inspected for inclusion.
Studies retrieved from the searches were reviewed inde-
pendently by two authors. Those that met the inclusion
criteria were shortlisted for data extraction. Disagreements
were resolved by discussion with a third author when
necessary.
Data extraction
Two reviewers extracted the data from shortlisted studies
on study type, setting, country, population, sample size,
mesh type, cost, sterilization techniques, type of surgery,
study population demographics, baseline characteristics,
intervention and postoperative complications. Data were
recorded in a standard form, and risk-of-bias assessments
were completed contemporaneously.
Fig. 2 Postoperative outcomes for hernia repair using
mosquito net mesh. There were 1085 hernias in total. Error
bars denote 95 per cent confidence intervals
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The primary outcome measure was the overall postop-
erative complication rate of hernia repair using MNM,
including haematoma, graft rejection, infection and pain.
Secondary outcome measures were comparisons between
MNM and CSM with regard to overall complication rates,
infection, chronic pain and haematoma formation.
Risk of bias
Risk of bias was assessed independently by two authors
using the Cochrane risk-of-bias checklist as published
in the Cochrane Handbook for Systematic Reviews
of Interventions version 5.1.019. This evaluated random
sequence generation and allocation concealment (selection
bias), blinding of participants and personnel (performance
bias), blinding of outcome assessment (detection bias),
incomplete outcome data (attrition bias), selective report-
ing (reporting bias), and other sources of bias. Each of
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Fig. 3 Forest plots comparing complications and pain after hernia repair with mosquito net versus commercial mesh. a Overall
complications, b severe or chronic pain, c infection and d haematoma or swelling. A Mantel–Haenszel fixed-effect model was used
for meta-analysis. Odds ratios are shown with 95 per cent confidence intervals
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these domains was assessed to be at low, medium or high
risk of bias.
Statistical analysis and data synthesis
Statistical analysis and data synthesis was conducted using
Review Manager version 5.3.5 (The Cochrane Collab-
oration, The Nordic Cochrane Centre, Copenhagen,
Denmark). Outcomes deemed relevant from the included
studies were assessed for estimation of treatment effects.
Odds ratios (ORs) and 95 per cent c.i. were calculated
for dichotomous outcomes. The mean difference with 95
per cent c.i. was calculated for continuous outcomes.
Meta-analyses were assessed for heterogeneity using the χ2
test and I2 statistic (considered significant if the χ2 statistic
had a P value of less than 0⋅100, or I2 was greater than
50 per cent). Where heterogeneity was found to be sig-
nificant, analyses were carried out using a random-effects
model. For non-randomized trials, data were represented
numerically and a cumulative analysis was performed.
Where possible, statistical analysis and data synthesis were
limited to studies reporting intention-to-treat protocols.
Where data weremissing, information was sought from the
study authors. If this information remained unavailable,
outcomes were inferred from existing data using statistical
methods. No subgroup or metaregression analysis was
performed.
Results
Description of studies
A total of 139 records were found through database
searching. Following application of data exclusion crite-
ria, nine studies were finally included (3 RCTs13,20,21, 1
non-RCT14 and 5 studies using prospectively developed
databases22–26). All studies took place in LEDCs, two
in the Indian subcontinent and seven in Africa. All four
controlled trials13,14,20,21 compared MNM with CSM; the
remaining studies focused solely on MNM.
Participants
Data from the nine studies13,14,20–26 were extracted to form
an aggregate quantitative synthesis including a total cohort
of 1360 patients (1085 patients in the MNM intervention
and 275 in the CSM control group). The mean age of
participants in the studies ranged from 33 to 52 years,
and the mean length of follow-up varied from 1month to
5 years (Tables S1 and S2, supporting information).
Assessment of bias
Risk-of-bias assessments were conducted for the four com-
parative studies that underwent meta-analysis (Table 1).
Two20,21 were found to be at low risk of bias and two13,14
had a high risk of selection and attrition bias.
Primary outcome
The overall postoperative complication rate was 9⋅3 per
cent, with haematoma formation or swelling accounting
for more than half of all complications. The incidence
of graft rejection was 0 per cent, infection 1⋅9 per
cent and impaired wound healing 0⋅4 per cent (Fig. 2).
Individual postoperative outcomes for each study are
summarized in Table S3 (supporting information).
Secondary outcomes
Owing to the limited number of RCTs, the single
non-RCT was included in the meta-analysis. Four studies
(3 RCTs, 1 non-RCT)13,14,20,21 compared MNM and
CSM with regard to overall complication rate, severe or
chronic postoperative pain, postoperative infection and
haematoma formation. A random-effects meta-analysis
did not demonstrate a statistically significant difference
between the two groups.
The overall complication rate revealed a pooled OR
of 0⋅99 (95 per cent c.i. 0⋅65 to 1⋅53; P= 0⋅98), with
no evidence of heterogeneity (I2 = 0 per cent, P= 0⋅91)
(Fig. 3a). For severe or chronic pain, the pooled OR was
2⋅52 (0⋅36 to 17⋅42; P= 0⋅35), with no heterogeneity (I2 = 0
per cent, P= 0⋅46) (Fig. 3b). For infection the pooled OR
was 0⋅56 (0⋅19 to 1⋅61; P= 0⋅28), with no heterogeneity
(I2 = 0 per cent, P= 0⋅66) (Fig. 3c), and for haematoma
the pooled OR was 1⋅05 (0⋅62 to 1⋅78; P= 0⋅86), with no
heterogeneity (I2 = 0 per cent, P= 0⋅97) (Fig. 3d).
Discussion
The results of the present meta-analysis support those of a
previous review27 and confirm the overall low rate of com-
plications usingMNM. This meta-analysis combined indi-
vidual data from different international centres with an
overall cohort of 1085 patients, and demonstrated that
patients undergoing inguinal hernia repair with MNM had
a low rate of postoperative complications, comparable to
that with CSM. Analysis of secondary outcome measures
was not able to demonstrate a statistically significant dif-
ference in overall complication rates, infection rates, inci-
dence of chronic pain and haematoma formation between
MNM and CSM.
© 2019 The Authors. www.bjsopen.com BJS Open 2019; 3: 429–435
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Sterilized MNM is a low-cost alternative to CSM and
has the potential to overcome some of the barriers to
prompt surgical treatment. Data in the individual RCTs
demonstrated that MNM can cost as little as €0⋅02 for
a 15× 15-cm strip that can be used in place of tradi-
tional CSM.
Issues surrounding the sterilization of MNM are impor-
tant. Previous research18 has suggested that not all MNMs
will be suitable for autoclave sterilization. One study17
showed that exposure of meshes to temperatures of 121 ∘C
caused some meshes to shrink by 30–50 per cent, with
degradation of physical material properties. Further work
should aim to create a standard protocol for the steriliza-
tion of MNM with no detrimental impact on its material
properties.
The main limitation of the present study was that it
included all trials published from inception to August 2018.
Change in clinical practice over this interval, as well as sur-
gical innovation and population change in LEDCs, may
be important. Design and methodological limitations in
the studies included in the quantitative synthesis may also
have influenced the results. One of the four studies in the
meta-analysis was non-randomized, and this would have
introduced a degree of both selection bias and informa-
tion bias secondary to potential confounders14. Of the
three RCTs included, one13 was deemed to have a high
risk of selection and attrition bias. The remaining five
studies22–26 were classified as prospective observational
studies, all of which had significant design and method-
ological limitations.
The primary outcome measure of complication rates
after mesh insertion may be less useful than the rate of her-
nia recurrence after repair, but this could not be considered
owing to the lack of long-term data provided. No study
included long-term follow-up of patients, so long-term
safety and efficacy remain uncertain. Traditional CSMs
undergo rigorous quality control testing, accounting for
their significantly higher cost compared with MNM, but
they are known to be durable. This highlights an important
knowledge gap in the long-term performance ofMNMand
demonstrates the need for a larger body of evidence before
definitive recommendations can be made.
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